caa a22 4500 445335998 CHVBK 20180317142755.0 cr unu---uuuuu 170323e20110401xx s 000 0 eng 10.1245/s10434-010-1455-8 doi (NATIONALLICENCE)springer-10.1245/s10434-010-1455-8 A Pilot Study Reporting Outcomes for Melanoma Patients of a Minimal Access Ilio-inguinal Dissection Technique Based on Two Incisions [Elektronische Daten] [Andrew Spillane, Monica Tucker, Sandro Pasquali] Background: A modified procedure for ilio-inguinal regional lymph node dissection (I-I RLND) involving 2 small skin incisions was evaluated with the aim of assessing surgical and oncological noninferiority compared with the traditional single, longitudinal incision I-I RLND. Materials and Methods: A total of 20 melanoma patients with positive groin lymph nodes who had traditional I-I RLND were compared with 20 patients who had a minimal access I-I RLND using 2 small surgical access incisions of 3-6cm in length—one sited below and one above the inguinal ligament. Clinical, staging features, number of lymph nodes retrieved, length of hospital stay, time drains remained in situ, morbidity (wound infections, dehiscence, hematoma, seroma, and lymphedema), and disease free survival were compared. Results: Patients in the groups were comparable with the exception that the minimal access I-I RLND group had a higher rate of AJCC stage N3 disease (60% vs 20%; P=.03) and more cases with extranodal spread (45% vs 15%; P=.041). After a median follow-up of 5months (range 1-8) for the minimal access group and median 13months (range 1-30) for the standard group there were no differences in disease-free survival (P=.13). Retrieved lymph node counts were similar (P=.34) including for the inguinal and pelvic components of the operations separately. No significant differences in wound complications or rates of early lymphedema were observed. Conclusions: At early follow-up, minimal access I-I RLND is feasible and noninferior to single longitudinal incision I-I RLND in regard to surgical morbidity and oncological outcome. Further evaluation is progressing. Society of Surgical Oncology, 2010 Spillane Andrew Sydney Medical School, The University of Sydney, Sydney, Australia aut Tucker Monica Melanoma Institute Australia, Sydney, Australia aut Pasquali Sandro Melanoma Institute Australia, Sydney, Australia aut Annals of Surgical Oncology Springer-Verlag 18/4(2011-04-01), 970-976 1068-9265 18:4<970 2011 18 10434 https://doi.org/10.1245/s10434-010-1455-8 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1245/s10434-010-1455-8 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Spillane Andrew Sydney Medical School, The University of Sydney, Sydney, Australia aut NATIONALLICENCE 700 1- Tucker Monica Melanoma Institute Australia, Sydney, Australia aut NATIONALLICENCE 700 1- Pasquali Sandro Melanoma Institute Australia, Sydney, Australia aut NATIONALLICENCE 773 0- Annals of Surgical Oncology Springer-Verlag 18/4(2011-04-01), 970-976 1068-9265 18:4<970 2011 18 10434 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer